GlucotrackGCTK
13F holders, Q2 2026 (June 30)19holders +6
9new positions
3sold out
1famous investor
$0.32avg. 13F price*
At the end of Q2 2026, 19 institutions reported holding Glucotrack Inc. (GCTK) in their 13F filings, up 6 from Q1 2026. 9 opened new positions and 3 sold out. The largest holders were HRT Financial LP ($65K), Jane Street Group, LLC ($41K) and Citadel Advisors ($25K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $86K |
| Exits | 3 | $3K |
All 13F filers, Q1 2026 → Q2 2026: 445,594 shares bought and 17,518 shares sold, net +428,076 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| HRT Financial LP | 0.00% | Add +405.6% | 205,442 | $65K |
| Jane Street Group, LLC | 0.00% | New | 128,459 | $41K |
| Citadel Advisors | 0.00% | New | 79,530 | $25K |
| Ikarian Capital, LLC | 0.00% | No change | 45,830 | $15K |
| Geode Capital Management, LLC | 0.00% | Reduce -27.2% | 34,207 | $11K |
| Virtu Financial LLC | 0.00% | New | 18,726 | $6K |
| Granite Islands Private Wealth, LLC | 0.00% | New | 15,700 | $5K |
| Boothbay Fund Management, LLC | 0.00% | No change | 13,525 | $4K |
| UBS Group AG | 0.00% | Add +1800.7% | 13,343 | $4K |
| Citigroup Inc. | 0.00% | New | 12,872 | $4K |
| Susquehanna International Group, LLP | 0.00% | New | 10,546 | $3K |
| Alerus Financial NA | 0.00% | No change | 4,000 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 3,442 | $1K |
| Barclays PLC | 0.00% | New | 1,259 | $402 |
| PlanVest Financial, Inc | 0.00% | New | 1,000 | $319 |
| Tradewinds Capital Management, LLC | 0.00% | New | 50 | $16 |
| NFSG Corp | 0.00% | No change | 34 | $11 |
| SBI Securities Co., Ltd. | 0.00% | No change | 9 | $3 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is GCTK's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.